Roy R. Teller

Array ( [id] => 6492402 [patent_doc_number] => 20100093609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PRODRUGS OF TRICIRIBINE AND TRICIRIBINE PHOSPHATE' [patent_app_type] => utility [patent_app_number] => 12/593709 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12653 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093609.pdf [firstpage_image] =>[orig_patent_app_number] => 12593709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320454 [patent_doc_number] => 20100113368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'CHOLESTEROL LOWERING PROTEIN HYDROLYSATES' [patent_app_type] => utility [patent_app_number] => 12/532193 [patent_app_country] => US [patent_app_date] => 2008-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113368.pdf [firstpage_image] =>[orig_patent_app_number] => 12532193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452701 [patent_doc_number] => 20090068738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 12/049034 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41659 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068738.pdf [firstpage_image] =>[orig_patent_app_number] => 12049034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887561 [patent_doc_number] => 20080261893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'TOPICAL CORNEAL ANALGESIA USING NEUROTENSIN RECEPTOR AGONISTS AND SYNERGISTIC NEUROTENSIN COMBINATIONS WITHOUT DELAYING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 12/047219 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5147 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261893.pdf [firstpage_image] =>[orig_patent_app_number] => 12047219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720066 [patent_doc_number] => 20080242589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'SYNTHETIC LIPID MIXTURES FOR THE PREPARATION OF A RECONSTITUTED SURFACTANT' [patent_app_type] => utility [patent_app_number] => 12/043177 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2050 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242589.pdf [firstpage_image] =>[orig_patent_app_number] => 12043177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867539 [patent_doc_number] => 20080146598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Combinatorial drug therapy using polymer-drug conjugates' [patent_app_type] => utility [patent_app_number] => 12/072070 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146598.pdf [firstpage_image] =>[orig_patent_app_number] => 12072070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823153 [patent_doc_number] => 20080227756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'USE OF BISPHOSPHONATES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA' [patent_app_type] => utility [patent_app_number] => 12/016588 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6454 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227756.pdf [firstpage_image] =>[orig_patent_app_number] => 12016588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320324 [patent_doc_number] => 20100113333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/520364 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37901 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113333.pdf [firstpage_image] =>[orig_patent_app_number] => 12520364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6421335 [patent_doc_number] => 20100151003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'EGFR BINDING PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/514622 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24599 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151003.pdf [firstpage_image] =>[orig_patent_app_number] => 12514622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710354 [patent_doc_number] => 08834920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Liposome composition for targeting egfr receptor' [patent_app_type] => utility [patent_app_number] => 12/513383 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 25165 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12513383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272123 [patent_doc_number] => 20090075899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Inhibiting collagen-induced platelet aggregation and activation with peptide variants' [patent_app_type] => utility [patent_app_number] => 12/001258 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27491 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075899.pdf [firstpage_image] =>[orig_patent_app_number] => 12001258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81776 [patent_doc_number] => 07745404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/952729 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10171 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745404.pdf [firstpage_image] =>[orig_patent_app_number] => 11952729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81781 [patent_doc_number] => 07745409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Methods and compositions for the treatment of gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 11/949340 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26303 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745409.pdf [firstpage_image] =>[orig_patent_app_number] => 11949340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6551156 [patent_doc_number] => 20100222546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/312766 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18120 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222546.pdf [firstpage_image] =>[orig_patent_app_number] => 12312766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497588 [patent_doc_number] => 20100093982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'DEVICE AND METHOD FOR PRECIPITATION OF PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/520117 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4487 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093982.pdf [firstpage_image] =>[orig_patent_app_number] => 12520117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579126 [patent_doc_number] => 07833969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules' [patent_app_type] => utility [patent_app_number] => 11/942598 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 23188 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833969.pdf [firstpage_image] =>[orig_patent_app_number] => 11942598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579139 [patent_doc_number] => 07833970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules' [patent_app_type] => utility [patent_app_number] => 11/942620 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 23153 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833970.pdf [firstpage_image] =>[orig_patent_app_number] => 11942620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080176 [patent_doc_number] => 20110142864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules' [patent_app_type] => utility [patent_app_number] => 11/942588 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142864.pdf [firstpage_image] =>[orig_patent_app_number] => 11942588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968991 [patent_doc_number] => 20110150849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules' [patent_app_type] => utility [patent_app_number] => 11/942561 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150849.pdf [firstpage_image] =>[orig_patent_app_number] => 11942561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080177 [patent_doc_number] => 20110142865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules' [patent_app_type] => utility [patent_app_number] => 11/942607 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23088 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142865.pdf [firstpage_image] =>[orig_patent_app_number] => 11942607 [rel_patent_id] =>[rel_patent_doc_number] =>)